Abstract
The term “miniantibodies” describes artificial multivalent or multispecific recombinant antibody fragments. They resemble natural antibodies in carrying two or four binding sites with a flexible arrangement and a long “wing span” but they are much smaller, as they consist only of fusions of a scFv to an oligomerization module. Applications of multivalent and bispecific antibody fragments in a variety of formats have been reviewed (Plückthun and Pack 1997; Carter and Merchant 1997). Approaches to quantify the avidity gain achieved by the multivalency effect present in all the described miniantibody models have been reported (Crothers and Metzger 1972, Plückthun and Pack 1997, Müller et al. 1998b).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Arndt KM, Pelletier JN, Müller KM, Alber T, Michnick SW, Plückthun A (2000) A heterodimeric coiled-coil peptide pair selected in vivo from a designed library-versuslibrary ensemble. T Mol Biol 295:627–639
Bass S, Gu Q, Christen A (1996) Multicopy suppressors of prc mutant Escherichia coli include two HtrA (DegP) protease homologs (HhoAB), DksA, and a truncated R 1 pA. J Bacteriol 178: 1154–1161
Bass S, Gu Q, Christen A, Bothrnann H, Plückthun A (1998) Selection for a periplasmic factor improving phage display and functional periplasmic expression. Nature Biotechnol 16:376–380
Bothmann H, Plückthun A (2000) The periplasmic Escherichia coli peptidylprolyl cis, trans-isomerase FkpA. I. Increased functional expresssion of antibody fragments with and without cis-prolines. J Biol Chem 275:17100–17105
Burton DR (1985) Immunoglobulin G: functional sites. Mol Immunol 22:161–206
Carter P, Merchant AM (1997) Engineering antibodies for imaging and therapy. Curr Opinion Biotechnol 8:449–454
Crothers DM, Metzger H (1972) The influence of polyvalency on the binding properties of antibodies. Immunochemistry 9:341–357
Dürr E, Jelesarov I, Bosshard HR (1999) Extremely fast folding of a very stable leucine zipper with a strengthened hydrophobic core and lacking electrostatic interactions between helices. Biochemistry 38:870–880
Eisenberg D, Wilcox W, Eshita SM, Pryciak PM, Ho SP and DeGrado WF (1986) The design, synthesis, and crystallization of an alpha-helical peptide. Proteins 1:16–22
Ge L, Knappik A, Pack P, Freund C, Plückthun A (1995) Expressing antibodies in Escherichia coli. In: Antibody Engineering, 2nd edition, Borrebaeck CAK (ed) Oxford University Press, pp 229–266
Harbury PB, Zhang T, Kim PS, Alber T (1993) A switch between two-, three-, and fourstranded coiled coils in GCN4 leucine zipper mutants. Science 262:1401–1407
Hill RB, DeGrado WF (1998) Solution structure of a2D, a nativelike de novo designed protein. J Am Chem Soc 120:1138–1145
Horn U, Strittmatter W, Krebber A, Knüpfer U, Kujau M, Wenderoth R, Müller K, Matzku S, Plückthun A, Riesenberg D (1996) High volumetric yields of functional dimeric miniantibodies in Escherichia coli, using an optimized expression vector and high-cell-density fermentation under non-limited growth conditions. (1996) Appl Microbiol Biotechnol 46:524–532
Huston JS, Mudgett-Hunter M, Tai M-S, McCartney J, Warren F, Haber E, Oppermann H (1991) Protein engineering of single-chain Fv analogs and fusion proteins. Methods Enzymol 203:46–88
Jeffrey PD, Gorina S, Pavletich NP (1995) Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 Angstroms. Science 267:1498–1502
Jung S, Plückthun A (1997) Improving in vivo folding and stability of a single-chain Fv antibody fragment by loop grafting. Protein Engineering 10:959–966
Knappik A, Plückthun A (1994) An improved affinity tag based on the FLAG peptide for the detection and purification of recombinant antibody fragments. Bio Techniques 17:754–761
Knappik A, Plückthun A (1995) Engineered turns of a recombinant antibody improve its in vivo folding. Protein Engineering 8:81–89
Krebber A, Bornhauser S, Burmester J, Honegger A, Willuda J, Bosshard HR, Plückthun A (1997) Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system. J Irrmrrmmunol Meth 201:35–55
Lindner P, Guth B, Wülfing C, Krebber C, Steipe B, Müller F, Plückthun A (1992) Purification of native proteins from the cytoplasm and periplasm of Escherichia coli using IMAC and histidine tails: a comparison of proteins and protocols. Methods 4:41–56
Lindner P, Bauer K, Krebber A, Nieba L, Kremmer E, Krebber C, Honegger A, Klinger B, Mocikat R, Plückthun A (1997) Specific detection of his-tagged proteins with recombinant anti-his tag scFv-phosphatase or scFv-phage fusions. Bio Techniques 22:140–149
Maurer R, Meyer BJ, Ptashne M (1980) Gene regulation at the right operator (O R ) of bacteriophage I. O R 3 and autogenous negative control by repressor. J Mol Biol 139:147–161
Müller KM, Arndt KM, Strittmatter W, Plückthun A (1998a) The first constant domain (CH1 and CL) of an antibody used as heterodimerization domain for bispecific miniantibodies. FEBS Lett 422:259–264
Müller KM, Arndt KM, Plückthun A (1998b) Model and simulation of multivalent binding to fixed ligands. Anal Biochem 261:149–158
Müller KM, Arndt KM, Plückthun A (1998c) A dimeric bispecific miniantibody combines two specificities with avidity. FEBS Lett 432:45–49
Müller KM, Arndt KM, Alber T (2000) Protein Fusions to coiled-coil domains. Methods Enzymol 328: 261–282
Nieba L, Honegger A, Krebber C, Plückthun A (1997) Disrupting tne hydrophobic patches at the antibody variable/constant domain interface: improved in vivo folding and physical characterization of an engineered scFv fragment. Protein Engineering 10:435–444
O’Shea EK, Klemm JD, Kim PS, Alber T (1991) X-ray structure of the GCN4 leucine zipper, a two-stranded, parallel coiled coil. Science 254:539–544
Pack P (1994) PhD Thesis, Universität München, Germany
Pack P, Knappik A, Krebber C, Plückthun A (1992) Mono- and bivalent antibody fragments produced in E. coli: binding properties and folding in vivo. In: Harnessing Biotechnology for the 21st Century. American Chemical Society Conference Proceedings Series. Ladisch MR and Bose A (eds.) ACS
Pack P, Plückthun A (1992) Miniantibodies: Use of amphipathic helices to produce functional, flexibly linked dimeric Fv fragments with high avidity in Escherichia coli. Biochemistry 31:1579–1584
Pack P, Kujau M, Schroeckh V, Knüpfer U, Wenderoth R, Riesenberg D, Plückthun A (1993) Improved bivalent miniantibodies, with identical avidity as whole antibodies, produced by high cell density fermentation of Escherichia coli. Biotechnology 11:1271–1277
Pack P, Müller K, Zahn R, Plückthun A (1995) Tetravalent miniantibodies with a high avidity assembling in Escherichia coli. J Mol Biol 246:28–34
Plückthun A and Pack P (1997) New protein engineering approaches to multivalent and bispecific antibody fragments. Immunotechnology 3: 83–105
Plückthun A, Krebber A, Krebber C, Horn U, Knüpfer U, Wenderoth R, Nieba L, Proba K, Riesenberg D (1996) Producing antibodies in Escherichia coli: From PCR to fermentation. In: Antibody Engineering: A Practical approach. McCafferty J and Hoogenboom HR (eds), IRL press, Oxford, pp 203–252
Rheinnecker M, Hardt C, Ilag LL, Kufer P, Gruber R, Hoess A, Lupas A, Rottenberger C, Plückthun A, Pack P (1996) Multivalent antibody fragments with high functional affinity for a tumor-associated carbohydrate antigen. J Immunol 157:2989–2997
Rudolph R, Lilie H (1996) In vitro folding of inclusion body proteins. FASEB J 10:49–56
Schroeckh V, Kujau M, Knüpfer U, Wenderoth R, Mörbe J, Riesenberg D (1996) Formation of recombinant proteins in Escherichia coli under control of a nitrogen regulated promoter at low and high cell densities. J. Biotechnol. 49:45–58
Willuda J, Honegger A, Waibel R, Schubiger A, Stahel R, Zangemeister-Wittke U, Plückthun A (1999) High thermal stability is essential for tumor targeting of antibody fragments: Engineering of a humanized anti-epithelial glycoprotein-2 (epithelial cell adhesion molecule) single-chain Fv fragment. Cancer Research 59:5758–5767
Yanisch-Perron C, Vieira J, Messing J (1985) Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M 13mp 18 and pUC19 vectors. Gene 33:103–119
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Lindner, P., Plückthun, A. (2001). Miniantibodies. In: Kontermann, R., Dübel, S. (eds) Antibody Engineering. Springer Lab Manuals. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04605-0_43
Download citation
DOI: https://doi.org/10.1007/978-3-662-04605-0_43
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-41354-7
Online ISBN: 978-3-662-04605-0
eBook Packages: Springer Book Archive